Pleiotropic effects of human papillomavirus type 16 E6 oncogene expression in human epithelial cell lines

References

1. Brown J., Higo H., McKalip A., Herman B. 1997; Human papillomavirus (HPV) 16 E6 sensitizes cells to atractyloside-induced apoptosis: role of p53, ICE-like proteases and the mitochondrial permeability transition. Journal of Cellular Biochemistry 66:245–255
   [Google Scholar]
2. Charvat S., Chignol M. C., Souchier C., Le Griel C., Schmitt D., Serres M. 1998; Cell migration and MMP-9 secretion are increased by epidermal growth factor in HaCaT-ras transfected cells. Experimental Dermatology 7:184–190
   [Google Scholar]
3. Chen J. J., Reid C. E., Band V., Androphy E. J. 1995; Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269:529–531
   [Google Scholar]
4. Crook T., Wrede D., Vousden K. H. 1991; p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6:873–875
   [Google Scholar]
5. Daniel B., Rangarajan A., Mukherjee G., Vallikad E., Krishna S. 1997; The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. Journal of General Virology 78:1095–1101
   [Google Scholar]
6. Desantes C., Hallez S., Alphen P. V., Burny A. 1992; Transcriptional activation of several heterologous promoters by the E6 protein ofhumanpapillomavirus type 16. JournalofVirology 66:325–333
   [Google Scholar]
7. Dey A., Atcha I. A., Bagchi S. 1997; HPV 16 E6 oncoprotein stimulates the transforming growth factor-beta 1 promoter in fibroblasts through a specific GC-rich sequence. Virology 228:190–199
   [Google Scholar]
8. Etscheid B. G., Foster S. A., Galloway D. A. 1994; The E6 protein of human papillomavirus type 16 functions as a transcriptional repressor in a mechanism independent of the tumor suppresser protein, p53. Virology 205:583–585
   [Google Scholar]
9. Faraldo M. M., Deugnier M. A., Lukashev M., Thierry J. P., Glukhova M. A. 1998; Perturbation of beta1-integrin function alters the development of murine mammary gland. EMBO Journal 17:2139–2147
   [Google Scholar]
10. Fishman R. B., Hatten M. E. 1993; Multiple receptor systems promote CNS neural migration. Journal of Neuroscience 13:3485–3495
    [Google Scholar]
11. Hanahan D., Folkman J. 1996; Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364
    [Google Scholar]
12. Harlow E., Lane D. 1988 Antibodies: A Laboratory Manual Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
13. Juliano R. L. 1993; The role of β 1 integrins in tumors. Seminars in Cancer Biology 4:277–283
    [Google Scholar]
14. Keely P. J., Westwick J. K., Whitehead I. A., Der J. C., Parise L. V. 1997; Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 390:632–636
    [Google Scholar]
15. Keely P., Parise L., Juliano R. 1998; Integrins and GTPases in tumour cell growth, motility and invasion. Trends in Cell Biology 8:101–106
    [Google Scholar]
16. Kinoshita T., Shirasawa H., Shino Y., Moriya H., Desbarats L., Eilers M., Simizu B. 1997; Transactivation of prothymosin a and c-myc promoters by human papillomavirus type 16 E6 protein. Virology 232:53–61
    [Google Scholar]
17. Kiyono T., Hiraiwa A., Fujita M., Hayashi Y., Akiyama T., Ishibashi M. 1997; Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proceedings of the National Academy of Sciences, USA 94:11612–11616
    [Google Scholar]
18. Lee S. S., Weiss R. S., Javier R. T. 1997; Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proceedings of the National Academy of Sciences, USA 94:6670–6675
    [Google Scholar]
19. Lehman T. A., Modali R., Boukamp P., Stanek J., Bennett W. P., Welsh J. A., Metcalf R. A., Stampfer M. R., Fusenig N., Rogan E. M. 1993; p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14:833–839
    [Google Scholar]
20. Matter M. L., Zhang Z., Nordstedt C., Ruoslahti E. 1998; Thealpha5beta1 integrin mediates elimination of amyloid-beta peptide and protects against apoptosis. Journal of Cell Biology 141:1019–1030
    [Google Scholar]
21. Meredith J. E., Schwartz M. A. 1997; Integrins, adhesion and apoptosis. Trends in Cell Biology 78:146–150
    [Google Scholar]
22. Pan H., Griep A. E. 1995; Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes & Development 9:2157–2169
    [Google Scholar]
23. Rapp L., Chen J. J. 1998; The papillomavirus E6 proteins. Biochimica et Biophysica Acta 1378:F1–19
    [Google Scholar]
24. Rozzo C., Chiesa V., Caridi G., Pagnan G., Ponzoni M. 1997; Induction of apoptosis in human neuroblastoma cells by abrogation of integrin-mediated cell adhesion. International Journal of Cancer 70:688–698
    [Google Scholar]
25. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
26. Scatena M., Almeida M., Chaisson M. L., Fausto N., Nicosia R. F., Giachelli C. M. 1998; NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. Journal of Cell Biology 141:1083–1093
    [Google Scholar]
27. Scheffner M., Werness B. A., Huibregtse J. M., Levine A. J., Howley P. M. 1990; The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136
    [Google Scholar]
28. Schwartz M. A. 1997; Integrins, oncogenes and anchorage independence. Journal of Cell Biology 139:575–578
    [Google Scholar]
29. Sheetz M. P., Felsenfeld D. P., Galbraith C. G. 1998; Cell migration:regulation offorce on extracellular-matrix-integrin complexes. Trends in Cell Biology 8:51–54
    [Google Scholar]
30. Sherman L., Schlegel R. 1996; Serum and calcium induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papilloma virus type 16. Journal of Virology 70:3269–3279
    [Google Scholar]
31. Shirasawa H., Jin M. H., Shimizu K., Akutsu N., Shino Y., Simizu B. 1994; Transcription-modulatory activity of full-length E6 and E6*I proteins of human papillomavirus type 16. Virology 203:36–42
    [Google Scholar]
32. Skobe M., Rockwell P., Goldstein N., Vosseler S., Fusenig N. E. 1997; Halting angiogenesis suppresses carcinoma cell invasion. Nature Medicine 3:1222–1227
    [Google Scholar]
33. Steller M. A., Zou Z., Schiller J. T., Baserga R. 1996; Transformation by human papillomavirus 16 E6 and E7: role of the insulin-like growth factor 1 receptor. Cancer Research 56:5087–5091
    [Google Scholar]
34. Storey A., Thomas M., Kalita A., Harwood C., Gardil D., Mantovani F., Breuer J., Leigh I. M., Matlashewski G., Banks L. 1998; Role of p53 polymorphism in the development of human-papillomavirus-associated cancer. Nature 393:229–234
    [Google Scholar]
35. Tergaonkar V., Mythily D. V., Krishna S. 1997; Cytokeratin patterns of expression in human epithelial cell lines correlate with transcriptional activity of the human papillomavirus type 16 upstream regulatory region. Journal of General Virology 78:2601–2606
    [Google Scholar]
36. Thomas M., Matlashewski G., Pim D., Banks L. 1996; Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation. Oncogene 13:265–273
    [Google Scholar]
37. Tong X., Howley P. M. 1997; The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proceedings of the National Academy of Sciences, USA 94:4412–4417
    [Google Scholar]
38. Tong X., Boll W., Kirchhausen T., Howley P. M. 1998; Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1. Journal of Virology 72:476–482
    [Google Scholar]
39. Vande Pol S. B., Brown M. C., Turner C. E. 1998; Association of bovine papillomavirus type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene 16:43–52
    [Google Scholar]
40. Wahl A. F., Donaldson K. L., Fairchild C., Lee F. Y., Foster S. A., Demers G. W., Galloway D. A. 1996; Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis. Nature Medicine 2:72–79
    [Google Scholar]
41. Werness B. A., Levine A. J., Howley P. M. 1990; Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76–79
    [Google Scholar]
42. Xu C., Meikrantz W., Schlegel R., Sager R. 1995; The human papilloma virus 16 E6 gene sensitizes human mammary epithelial cells to apoptosis induced by DNA damage. Proceedings of the National Academy of Sciences, USA 92:7829–7833
    [Google Scholar]
43. Yu Y., Li C. Y., Little J. B. 1997; Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells. Oncogene 14:1661–1667
    [Google Scholar]
44. zur Hausen H. 1996; Papillomavirus infections – a major cause of human cancers. Biochimica et Biophysica Acta 1288:55–78
    [Google Scholar]